/

Batteries & E-Mobility

/

Photocure

Photocure

Photocure

Verified Nov 2026

Batteries & E-Mobility

·

Oslo, Oslo

·

Since 1993

Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.

Photocure

Verified Nov 2026

AT A GLANCE

Founded

1993

Headquarters

Oslo, Oslo

Employees

100-200

Ownership

Photocure at a glance

Revenue

$50-100M

Est. band

Employees

100-200

Founded

1993

Headquarters

Oslo, Oslo

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.

At a glance

Attribute

Detail

Founded

1993

Headquarters

Oslo, Oslo

Employees

100-200

Revenue

$50-100M (estimated)

Primary capability

Batteries & E-Mobility

What Photocure makes

Photocure manufactures and commercializes photodynamic diagnostic and therapeutic products including Hexvix and Cysview for blue light cystoscopy detection of bladder cancer, with pipeline product Cevira targeting HPV infections and precancerous cervical lesions.

Latest developments

Facilities

Photocure is headquartered in Oslo, Oslo. Public sources also reference these locations:

Company details

The company operates commercial teams across North America and Europe and is publicly traded on the Oslo Stock Exchange under ticker PHO. Photocure was founded in 1993, has an estimated 100-200 employees, and is headquartered in Oslo, Oslo.

Frequently asked questions

What does Photocure make?

Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.

Where is Photocure headquartered?

Photocure is headquartered in Oslo, Oslo (4 Hoffsveien, Oslo, Oslo, 0275).

When was Photocure founded?

Photocure was founded in 1993.

How big is Photocure?

Photocure has an estimated 100-200 employees, with revenue in the $50-100M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Oslo, Oslo (HQ)Headquarters · Norway
Oslo, Oslo (HQ)4 Hoffsveien, Oslo, Oslo, 0275, NorwayHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.